The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...
Jan 12, 2018
0
82
A blood screening result that suggests prostate cancer is bound to provoke high anxiety - even though up to 80 percent of those findings turn out to be false positives.
Dec 28, 2011
0
0
Scientists have identified what may be the Peyton Manning of prostate cancer. It's a protein that's essential for the disease to execute its game plan: Grow and spread throughout the body.
Jul 24, 2012
0
0
Prostate cancer can grow slowly and pose little threat to patients, or it can metastasize quickly, causing severe pain and death. But as of now, it's nearly impossible to determine which type of cancer a patient has during ...
Apr 2, 2019
0
12
Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena in which cells cease to divide in response to DNA damaging agents, including many chemotherapies. ...
Jul 6, 2015
0
89
Researchers at Carnegie Mellon University have developed a new approach to improve training for cryosurgery, a procedure used to treat prostate cancer by freezing and destroying the diseased tissues. The new approach will ...
Aug 3, 2015
0
14
UCLA researchers have discovered a previously unrecognized type of progenitor cell that, though rare in most regions of the human prostate, is found in uncommonly high numbers in inflamed areas of the gland. These progenitor ...
Dec 7, 2016
0
9
Cancer is an evolutionary disease. The same forces that turned dinosaurs into birds turn normal cells into cancer: genetic mutations and traits that confer a survival advantage.
May 2, 2023
0
6
For about 90 percent of men with prostate cancer, the cancer remains localized to the primary site, resulting in a five-year survival rate of almost 100 percent. Unfortunately, the remaining 10 percent of patients develop ...
May 9, 2019
0
84
In more than half of all prostate tumors, two genes—one for a transcription factor called ERG, the other a testosterone-triggered gene called TMPRSS2—become fused together, resulting in excess ERG expression. The TMPRSS2-ERG ...
Aug 3, 2018
0
24
